Dr. Stephen E. Wolverton, MD

Expert Publications

• Monitoring for adverse effects from systemic drugs used in dermatology.
• Pemphigus foliaceus with epidermal detachment: adverse events from patch testing.
• Suggested guidelines for patient monitoring: hepatic and hematologic toxicity attributable to systemic dermatologic drugs.
• The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.
• Optimizing clinical use of azathioprine with newer pharmacogenetic data.
• Controversies in dermatologic drug therapy.
• Can short courses of systemic corticosteroids truly cause osteonecrosis?
• Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis.
• Systemic drug therapy for psoriasis. The most critical issues.
• Recent trends in systemic psoriasis treatment costs.
• Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.
• Top-accessed article: topical rapamycin.
• Drug hypersensitivity syndrome in a patient receiving vismodegib.
• Practice Gaps: Drug Reactions.
• Medical Malpractice in Dermatology-Part I: Reducing the Risks of a Lawsuit.

Media Releases

Get to know Dermatologist Dr. Stephen E. Wolverton, who serves the population of Indianapolis, Indiana.

Stephen E. Wolverton, MD is a dermatologist currently practicing with Indiana University Health. Indiana University Health is the largest network of physicians in the state of Indiana. A unique partnership with Indiana University School of Medicine, one of the nation’s leading medical schools, gives patients access to leading-edge medicine and treatment options that are available first, and often only, at IU Health.

After receiving his undergraduate degree at Ball State University in 1975, Dr. Wolverton attended medical school at Indiana University School of Medicine and received his MD degree in 1979.  Dr. Wolverton initially pursued a career in Family Practice, completing his residency at St. Elizabeth Medical Center in Dayton, Ohio in 1982. This residency was followed by a year in a junior faculty position at the same FP residency program.

Dr. Wolverton initiated his Dermatology career completing his residency at Wright State University in Dayton, Ohio, from 1983 to 1985. Subsequent faculty positions have included Wright State University (Fellow Instructor 1986-1987), Ohio State University (1987-1990, including a year as Acting Division Director), and the long-term faculty position in the Dermatology Department at the Indiana University School of Medicine (1990-present). His current position is Theodore Arlook Professor of Clinical Dermatology and Professor of Clinical Dermatology.

Dr. Wolverton’s long-term academic interest has been systemic drug use in Dermatology, focusing on all aspects of Drug Safety, including a more recent focus in the complex area of Drug Interactions. He is best known for his series of four books concerning Dermatologic Drug Therapy: Systemic Drugs for Skin Diseases (published in 1991) and Comprehensive Dermatologic Drug Therapy (initially published in 2001, 2nd edition published in February 2007, with the 3rd edition of this title published late Fall 2012).

In addition, for 20 years he has been the Course Director for the Introduction to Cutaneous Biology course for Dermatology residents throughout the US and Canada that is sponsored by the Indiana University Department of Dermatology. 

He is a frequent visiting professor at various Dermatology residency programs, along with various state and local Dermatologic medical societies. He continues his strong interest in Dermatology resident education full-time at IU and during many of the visiting professorships.

Dermatology is the branch of medicine dealing with the skin, nails, hair and its diseases. It is a specialty with both medical and surgical aspects. A dermatologist treats diseases, in the widest sense, as well as some cosmetic problems of the skin, scalp, hair, and nails.

Recommended Articles

• Melanoma: Get the Facts

  Melanoma is a form of skin cancer that develops in the melanocytes, which are the cells that determine your skin color because of the melanin pigment. Melanoma has the ability to develop in various parts of the body including the eyes, nails, mouth, as well as some internal organs such as the...

• Treatments for Rosacea

  Treatment for rosacea is determined by which sub-type you have. Although there is no cure for the condition, there are several treatment options available to control signs and symptoms. Depending on symptoms, your doctor will tailor a treatment plan that best suits you.There are four sub-types of...

• Syphilis: If Left Untreated, What Happens to the Body?

  What is Syphilis?Syphilis is a venereal disease that is transmitted through vaginal, anal, or oral sexual contact. It can also be passed from a pregnant mother to her unborn baby, or from an infected blood donor to a person who receives the blood contaminated with syphilitic bacteria through a...

• The Effects of Sun Damage

  New research has reported that exposure to pollution may double the skin damage caused by the Sun. The study reports that extreme weather and smoking may also increase the damage caused by ultraviolet radiations. The results of the study were presented at the annual meeting of the American Academy...

• What Does Triamcinolone Treat?

  Triamcinolone topical is used for the treatment of various skin conditions and their symptoms, such as redness, inflammation, itching, and other discomforts. This topical medication is also a corticosteroid and only available through prescription. Other available forms of triamcinolone are:...

• How to Combat Atopic Dermatitis

  Atopic dermatitis, sometimes referred to as eczema, is a common and frustrating skin condition characterized by inflammation, dry skin, and rashes. It is a kind of allergy that affects the body’s first line of defense against infectious agents. It is more commonly seen in children; they normally...